Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling

Intimal sarcomas (IS) are rare malignant mesenchymal tumors arising in large blood vessels of the systemic and pulmonary circulation and also in the heart. They are morphologically similar to other spindle cell, poorly differentiated sarcomas. The prognosis is poor and depends mainly on surgical options. Three cases of IS were collected from two institutions. Clinical data were retrieved and histological study was performed. A wide immunohistochemical panel was analyzed. FISH of MDM2 gene was performed, and a molecular study with NGS was implemented in all cases. The mean age of our cases was 54 years. Histologically, the tumors presented a diffuse growth pattern with heterogeneous atypical epithelioid or spindle cells and extensive thrombosed areas. All cases presented intense immunoexpression for MDM2, CDK4, CD117, c-myc, PDGFRA, and p16. PDGFRA, HTERT, and pan-TRK gained expression, while p16 lost intensity, being weaker in both the local recurrences and xenografts. The three cases showed amplification of MDM2 by FISH. NGS analysis revealed amplifications in the CDK4, PDGFRA, and KIT genes, together with BRAF mutation and KRAS amplification. P16 was expressed in all cases, losing intensity in local recurrence and xenografts. Two new alterations, a BRAF mutation and a KRAS amplification, were detected by NGS in different tumors, opening up new therapeutic options for these patients.

[1]  B. Rah,et al.  Telomere Attrition With Concomitant hTERT Overexpression Involved in the Progression of Gastric Cancer May Have Prognostic and Clinical Implications in High-Risk Population Group From North India , 2022, Frontiers in Oncology.

[2]  K. Tsuchihashi,et al.  Myxoid type and non-myxoid type of intimal sarcoma in large vessels and heart: review of histological and genetic profiles of 20 cases , 2022, Virchows Archiv.

[3]  David C. Jones,et al.  Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature , 2021, Modern Pathology.

[4]  R. Sciot MDM2 Amplified Sarcomas: A Literature Review , 2021, Diagnostics.

[5]  M. Sbaraglia Intimal Sarcoma , 2020, Encyclopedia of Pathology.

[6]  A. Llombart‐Bosch,et al.  Solitary fibrous tumor: a case series identifying pathological adverse factors—implications for risk stratification and classification , 2019, Virchows Archiv.

[7]  J. Roszik,et al.  Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets , 2019, Cancers.

[8]  E. Rasmussen,et al.  Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia. , 2019, Blood advances.

[9]  Xin Li,et al.  A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance , 2019, Genes & diseases.

[10]  Narasimhan P. Agaram,et al.  GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions , 2019, Modern Pathology.

[11]  Robin L. Jones,et al.  Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network , 2019, Cancer.

[12]  M. Warmuth,et al.  H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers , 2018, Nature Medicine.

[13]  Moriah H Nissan,et al.  OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.

[14]  S. Ishikawa,et al.  Cardiac intimal sarcoma with PDGFRβ mutation and co-amplification of PDGFRα and MDM2: an autopsy case analyzed by whole-exome sequencing , 2017, Virchows Archiv.

[15]  AACR Project GENIE: Powering Precision Medicine through an International Consortium. , 2017, Cancer discovery.

[16]  F. Collin,et al.  Intimal Sarcoma Is the Most Frequent Primary Cardiac Sarcoma: Clinicopathologic and Molecular Retrospective Analysis of 100 Primary Cardiac Sarcomas , 2014, The American journal of surgical pathology.

[17]  P. Dartevelle,et al.  Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .

[19]  Marc Ladanyi,et al.  Advances in sarcoma genomics and new therapeutic targets , 2011, Nature Reviews Cancer.

[20]  P. Marynen,et al.  Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma. , 2010, Cancer research.

[21]  Derek Y. Chiang,et al.  Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy , 2010, Nature Genetics.

[22]  C. Moran,et al.  Management of primary pulmonary artery sarcomas. , 2009, The Annals of thoracic surgery.

[23]  S. Blackmon,et al.  Management of primary cardiac sarcomas , 2008, Expert review of cardiovascular therapy.

[24]  U. Pastorino,et al.  Analysis of potential receptor tyrosine kinase targets in intimal and mural sarcomas , 2007, The Journal of pathology.

[25]  S. Knuutila,et al.  Undifferentiated Intimal Sarcoma of Large Systemic Blood Vessels: Report of 14 Cases With Immunohistochemical Profile and Review of the Literature , 2005, The American journal of surgical pathology.

[26]  Dr. Moritz Mandelstamm Über primäre Neubildungen des Herzens , 1923, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.

[27]  Kuang-Tai Kuo,et al.  Pulmonary Artery Sarcoma–A Case Report and Review of the Literature , 2004 .

[28]  E. Speel,et al.  Gains of 12q13–14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery , 2000, Virchows Archiv.

[29]  T. Mentzel,et al.  Intravascular (”intimal”) epithelioid angiosarcoma: clinicopathological and immunohistochemical analysis of three cases , 1999, Virchows Archiv.

[30]  P. Schlag,et al.  GLI gene expression in bone and soft tissue sarcomas of adult patients correlates with tumor grade. , 1999, Cancer research.

[31]  J. Goldblum,et al.  Epithelioid angiosarcoma of the pulmonary artery. , 1995, Human pathology.

[32]  Renu Virmani,et al.  Sarcomas of the great vessels. A clinicopathologic study , 1993, Cancer.

[33]  Y. Nakanuma,et al.  PRIMARY PULMONARY ARTERY SARCOMA. Report of Two Autopsy Cases Studied by Immunohistochemistry and Electron Microscopy, and Review of 110 Cases Reported in the Literature , 1988, Acta pathologica japonica.